OFD1: One gene, several disorders N Pezzella, G Bove, R Tammaro, B Franco American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2022 | 28 | 2022 |
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway N Del Gaudio, A Di Costanzo, NQ Liu, L Conte, C Dell’Aversana, G Bove, ... Molecular cancer 21 (1), 125, 2022 | 27 | 2022 |
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance L Montella, M Cuomo, N Del Gaudio, M Buonaiuto, D Costabile, ... International Journal of Cancer 153 (3), 476-488, 2023 | 17 | 2023 |
Interplay between m6A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives G Bove, S Amin, M Babaei, R Benedetti, A Nebbioso, L Altucci, ... International Journal of Cancer 153 (3), 464-475, 2023 | 10 | 2023 |
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis M Brindisi, S Barone, A Rossi, E Cassese, N Del Gaudio, ÁJF Morel, ... European Journal of Pharmacology 936, 175349, 2022 | 6 | 2022 |
Looking beyond the glioblastoma mask: is genomics the right path? L Montella, N Del Gaudio, G Bove, M Cuomo, M Buonaiuto, D Costabile, ... Frontiers in oncology 12, 926967, 2022 | 6 | 2022 |
iPSCs for modeling hepatotropic pathogen infections G Bove, AK Mehnert, VLD Thi iPSCs for Studying Infectious Diseases, 149-213, 2021 | 5 | 2021 |
Epitranscriptomics and epigenetics: two sides of the same coin? G Bove, N Del Gaudio, L Altucci Clinical Epigenetics 16 (1), 121, 2024 | 1 | 2024 |
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A R Pacifico, N Del Gaudio, G Bove, L Altucci, L Siragusa, G Cruciani, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1987-1994, 2022 | 1 | 2022 |
The m6A‐independent role of epitranscriptomic factors in cancer G Bove, M Crepaldi, S Amin, WL Megchelenbrink, A Nebbioso, V Carafa, ... International Journal of Cancer 155 (10), 1705-1713, 2024 | | 2024 |
Epi-Drugs Targeting RNA Dynamics in Cancer G Bove, I Lettiero, G Sgueglia, N Del Gaudio, L Altucci, C Dell’Aversana Cancer Research: An Interdisciplinary Approach, 361-388, 2023 | | 2023 |